LeMaitre (LMAT) director Roush gains 476 shares from PSU vesting

Rhea-AI Filing Summary

LeMaitre Vascular director John A. Roush reported equity awards and vesting activity, not open‑market trades. On February 26, 2026, he received a grant of 476 shares of common stock and 1 share from the exercise of dividend equivalent rights, bringing his directly held common stock to 3,942 shares. Related derivative dividend equivalent rights totaled 2.8963 following settlement linked to a Performance Share Unit (PSU) award granted on December 6, 2024, which vested one‑third when the performance condition was met, with the remainder vesting in equal annual installments over the next two years. An additional 181 shares are held indirectly by his spouse.

Insider Trade Summary

1 shares exercised/converted

Mixed 4 txns

Insider Roush John A

Role Director

Type	Security	Shares	Price	Value
Exercise	Dividend Equivalent Rights	1	$0.00	--
Grant/Award	Common Stock	476	$0.00	--
Exercise	Common Stock	1	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Dividend Equivalent Rights — 2.896 shares (Direct); Common Stock — 3,941 shares (Direct); Common Stock — 181 shares (Indirect, By spouse)

Footnotes (1)

1. These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 1/3 upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next two years. Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roush John A

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, 63 SECOND AVENUE

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A		476(1)	A	$0	3,941	D
Common Stock	02/26/2026		M		1(2)	A	$0(2)	3,942	D
Common Stock								181	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(3)	02/26/2026		M			1(3)	(3)	(3)	Common Stock	1	$0	2.8963	D

Explanation of Responses:

1. These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 1/3 upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next two years.

2. Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

3. These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Laurie A. Churchill, Attorney-in-fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did LMAT director John A. Roush report on this Form 4?

John A. Roush reported equity awards and vesting activity, not market trades. On February 26, 2026, he received common shares and settled dividend equivalent rights tied to a prior Performance Share Unit award granted in December 2024.

How many LeMaitre (LMAT) shares were granted to John A. Roush?

He received a grant of 476 shares of common stock on February 26, 2026. In addition, 1 share was acquired through exercise of dividend equivalent rights, increasing his directly held common stock position recorded in the filing.

What are the Performance Share Units mentioned in the LMAT Form 4 footnotes?

The filing describes a Performance Share Unit (PSU) award granted on December 6, 2024. One‑third vested when the performance condition was determined on February 26, 2026, with the remaining units vesting in equal annual installments over the next two years.

How many LeMaitre (LMAT) shares does John A. Roush hold directly after these transactions?

After the reported grant and related share settlement, he directly holds 3,942 shares of LMAT common stock. This total reflects the 476‑share award and the 1 share acquired from dividend equivalent rights conversion on February 26, 2026.

Are any LeMaitre (LMAT) shares attributed to John A. Roush held indirectly?

Yes. The Form 4 shows 181 shares of LMAT common stock held indirectly by his spouse. These are reported separately from his direct holdings and are identified in the filing as "By spouse" ownership.

Did the LMAT Form 4 show any open‑market buying or selling by John A. Roush?

No open‑market buying or selling is shown. The transactions are coded as awards and derivative exercises at a price of $0.00 per share, reflecting grants, PSU vesting, and dividend equivalent right settlements rather than market purchases or sales.